Reaction

Listless reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,245 reports · 75 co-occurring drugs

As of the last recalculation, Listless appears in 3,245 FAERS reports alongside 75 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 20.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Captopril	30	20.2	20.3
Oxazepam	50	15.1	15.2
Telmisartan	41	14.9	14.9
Ocrelizumab	101	10.8	10.8
Bisacodyl Suppositories	18	9.0	9.0
Biscodyl	18	8.9	8.9
Bisacodyl	18	8.2	8.3
Asenapine Maleate	11	8.2	8.2
Pramipexole	19	8.0	8.0
Axicabtagene Ciloleucel	11	7.2	7.2
Donepezil Hydrochloride	39	6.9	6.9
Cladribine	10	6.7	6.7
Doxepin Hydrochloride	13	6.6	6.6
Sotalol Hydrochloride	17	6.6	6.6
Finasteride	60	6.5	6.5
Tolterodine Tartrate	9	6.4	6.5
Levodopa	12	6.4	6.4
Amiodarone Hydrochloride	11	6.3	6.3
Palivizumab	15	6.3	6.3
Rosuvastatin Calcium	25	5.7	5.7
Guanfacine	7	5.7	5.7
Apalutamide	10	5.5	5.5
Desloratadine	9	5.4	5.4
Guaifenesin	25	5.3	5.3
Torsemide	27	5.3	5.3
Insulin Degludec	19	5.2	5.2
Rivastigmine	14	4.8	4.8
Methadone Hydrochloride	8	4.8	4.8
Fesoterodine Fumarate	8	4.7	4.7
Selexipag	19	4.7	4.7
Iohexol	6	4.6	4.7
Metoprolol Succinate Er Tablets	44	4.6	4.6
Vigabatrin	10	4.4	4.4
Brivaracetam	6	4.3	4.3
Valsartan And Hydrochlorothiazide	9	4.3	4.3
Meloxicam	37	4.1	4.1
Nintedanib	20	4.1	4.1
Amlodipine Besylate And Valsartan	7	4.1	4.1
Atomoxetine Hydrochloride	15	4.1	4.1
Rasagiline Mesylate	7	4.0	4.0
Baricitinib	6	4.0	4.0
Rotigotine	8	3.6	3.6
Suvorexant	7	3.5	3.5
Carbidopa And Levodopa	25	3.4	3.4
Liraglutide	26	3.4	3.4
Teriparatide	57	3.3	3.3
Tolvaptan	7	3.1	3.1
Exenatide	25	3.1	3.1
Dofetilide	5	3.1	3.1
Eszopiclone	12	3.0	3.0
Tofacitinib Citrate	6	2.9	2.9
Sofosbuvir	9	2.9	2.9
Risperidone	57	2.8	2.8
Cariprazine	4	2.8	2.8
Deferasirox	11	2.7	2.7
Fam-Trastuzumab Deruxtecan-Nxki	4	2.5	2.5
Pirfenidone	16	2.5	2.5
Fentanyl Citrate	7	2.5	2.5
Axitinib	7	2.3	2.3
Peginterferon Alfa-2A	19	2.3	2.3
Enzalutamide	20	2.2	2.2
Siponimod	3	2.2	2.2
Polatuzumab Vedotin	3	2.0	2.0
Peginterferon Beta-1A	4	2.0	2.0
Teriflunomide	13	1.8	1.8
Olaparib	6	1.8	1.8
Paricalcitol	4	1.8	1.8
Valbenazine	7	1.8	1.8
Abemaciclib	5	1.6	1.6
Varenicline Tartrate	19	1.5	1.5
Patiromer	3	1.4	1.4
Pimavanserin Tartrate	11	1.3	1.3
Relugolix	4	1.1	1.1
Nirmatrelvir And Ritonavir	9	1.1	1.1
Droxidopa	3	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.